Capital World Investors
IRWD icon

Capital World Investors’s Ironwood Pharmaceuticals IRWD Stock Holding History

Capital World Investors’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,030,000
Closed -$23.1M – 615
2020
Q4 		$23.1M Hold
2,030,000
– – ﹤0.01% 486
2020
Q3 		$18.3M Hold
2,030,000
– – ﹤0.01% 476
2020
Q2 		$20.9M Hold
2,030,000
– – 0.01% 434
2020
Q1 		$20.5M Hold
2,030,000
– – 0.01% 391
2019
Q4 		$27M Hold
2,030,000
– – 0.01% 400
2019
Q3 		$17.4M Hold
2,030,000
– – ﹤0.01% 421
2019
Q2 		$22.2M Sell
2,030,000
-393,820
-16% -$4.41M 0.01% 429
2019
Q1 		$27.5M Hold
2,423,820
– – 0.01% 399
2018
Q4 		$21M Hold
2,423,820
– – 0.01% 430
2018
Q3 		$37.5M Hold
2,423,820
– – 0.01% 403
2018
Q2 		$38.8M Hold
2,423,820
– – 0.01% 391
2018
Q1 		$31.3M Buy
2,423,820
+835,800
+53% +$10.4M 0.01% 388
2017
Q4 		$19.9M Hold
1,588,020
– – ﹤0.01% 431
2017
Q3 		$21M Hold
1,588,020
– – ﹤0.01% 428
2017
Q2 		$25.1M Hold
1,588,020
– – 0.01% 406
2017
Q1 		$22.7M Buy
+1,588,020
New +$21.7M 0.01% 411
2015
Q4 		– Sell
-1,761,150
Closed -$15.4M – 531
2015
Q3 		$15.4M Hold
1,761,150
– – ﹤0.01% 449
2015
Q2 		$17.8M Hold
1,761,150
– – ﹤0.01% 451
2015
Q1 		$23.6M Sell
1,761,150
-155,220
-8% -$2.04M 0.01% 429
2014
Q4 		$24.6M Hold
1,916,370
– – 0.01% 430
2014
Q3 		$20.8M Hold
1,916,370
– – 0.01% 426
2014
Q2 		$24.6M Sell
1,916,370
-53,730
-3% -$584K 0.01% 411
2014
Q1 		$20.3M Sell
1,970,100
-411,930
-17% -$4.63M 0.01% 421
2013
Q4 		$23.2M Hold
2,382,030
– – 0.01% 400
2013
Q3 		$23.6M Sell
2,382,030
-1,110,420
-32% -$10.9M 0.01% 393
2013
Q2 		$29.1M Buy
+3,492,450
New +$42.3M 0.01% 375

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Capital World Investors's IRWD Position: Q1 2021 in Review

Capital World Investors sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2021, closing a stake of 2,030,000 shares — an estimated $23.1M sold.

Capital World Investors first reported a position in IRWD in Q2 2013 and held it in 26 quarters. The position peaked at $38.8M in Q2 2018. 210 funds tracked by Wall St. Rank hold IRWD as of Q1 2021.

  • Capital World Investors reported no remaining Ironwood Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Capital World Investors sold 2,030,000 Ironwood Pharmaceuticals shares in Q1 2021, an estimated $23.1M.
  • Capital World Investors first reported a position in Ironwood Pharmaceuticals in Q2 2013 and held it in 26 quarters.
  • Capital World Investors's Ironwood Pharmaceuticals position peaked at $38.8M in Q2 2018.
  • 210 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2021.

Based on Capital World Investors's 13F filing for Q1 2021, filed 14 May 2021.